Keith Gomez, PhD MRCP FRCPath

Consultant Haematologist
Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, UK and Cancer Institute, University College London, London, UK

Presentation(s):

• PB0045 - A pilot, open-label, phase II clinical trial of nebulised recombinant tissue-plasminogen activator in patients with COVID-19 acute respiratory distress syndrome: the PACA trial

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM